SPDR S&P Pharmaceuticals ETF logo

SPDR S&P Pharmaceuticals ETF (XPH)

Market Closed
11 Jun, 20:00
ARCA ARCA
$
59. 77
+1.41
+2.416%
$
241.05M Market Cap
0.62% Div Yield
28,546 Volume
$ 58.36
Previous Close
Add Transaction
Day Range
58.73 60.05
Year Range
40.26 60.73
Want to track XPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

SPDR S&P Pharmaceuticals ETF Investors

Name Quantity Cost Value Profit ($) Gain (%)
JA
Jeff Ameen Spire Wealth Management
1,107 $59,877.63 $66,165.39 $6,287.76 10.5%
KPS
Kyle P. Smith NewEdge Wealth LLC
4,033 $173,393.2 $241,213.73 $67,820.53 39.11%
KVD
Kurt Van Dyken Lifeworks Advisors LLC
4,503 $243,567.27 $269,324.43 $25,757.16 10.57%
CAL
CoreCap Advisors LLC CoreCap Advisors LLC
41 $1,768.33 $2,452.21 $683.88 38.67%
Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. Envestnet Portfolio Solutions, Inc.
171,479 $7.23M $10.26M $3.03M 41.95%
Benjamin Carter
Benjamin Carter Turtle Creek Wealth Advisors, LLC
475 $25,693 $28,409.75 $2,716.75 10.57%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
400 $14,235.93 $23,924 $9,688.07 68.05%
AM
Allyson Mickool Florida Financial Advisors LLC
4,350 $243,648 $260,652 $17,004 6.98%
SummitTX Capital LP
SummitTX Capital LP SummitTX Capital LP
15,577 $842,560 $933,373.84 $90,813.84 10.78%
Matthew Francis Dean
Matthew Francis Dean Evelyn Partners Investment Management (Europe) Ltd.
4,250 $203,744.54 $254,532.5 $50,787.96 24.93%